Navigation Links
Delivering Molecular Imaging Solutions Across Clinical Specialties: Siemens Showcases New Technologies at RSNA 2007
Date:11/20/2007

is Siemens' solution for radioisotope production of 18-fluoride-based radiotracers, as well as production N-13, 0-15 and C-11 isotopes.

Tying it all together, Siemens Molecular Imaging (MI) University, a fundamental part of MI LifeNet - Siemens' customer care initiative - provides a substantive training resource for Siemens' customers. Today's molecular imaging professionals require continuous education, training and the ability to share results. Designed to be used by the interpreting physician, referring physician and technologist, MI University demonstrates the benefits of hybrid PET*CT and SPECT*CT systems, including when and how hybrid imaging influences patient management, through access to valuable clinical data and detailed case studies; video lectures; product information; and a tool for information exchange among peers.

Availability of FLT to NCI Research Sites

Siemens also recently announced that the National Cancer Institute has filed a cross-reference letter to a Type II Drug Master File that Siemens submitted to the U.S. Food and Drug Administration for its investigational 3'Deoxy-3'[18F] Fluorothymidine (F-18 FLT) imaging biomarker. The cross reference allows F-18 FLT to be produced and used by any principle investigator in an NCI multi-center clinical trial. In addition, the imaging biomarker will be available to independent investigators if they receive NCI approval. F-18 FLT is produced by PETNET Solutions or Molecular Imaging Biomarker Research, both subsidiary companies of Siemens Medical Solutions, Molecular Imaging. The imaging biomarker has been used in studies monitoring the proliferative activity of cancer cells and it is currently being used in Phase-I clinical trials at several research sites.

About Siemens Medical Solutions

Siemens Medical Solutions is one of the world's largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative stren
'/>"/>

SOURCE Siemens Medical Solutions
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Center for Molecular Medicine Only Regional Provider of Test Suggested in FDA Alert on Prescribing Codeine to Nursing Mothers
2. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
3. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
4. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
5. Glycominds Joins Biomolecular Photonic (BMP) Consortium to Develop New Molecular Imaging Technique
6. Former Pfizer Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics Inflammatory Disease Initiatives
7. Sunesis Pharmaceuticals to Present Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
8. Astex Drug Candidates to be Featured at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
9. Center for Molecular Medicine One of the First Midwest Labs to Offer Advanced Test for Patients with Metastatic Breast Cancer
10. Imaging Diagnostic Systems New Laser Breast Imaging Scanner Introduced in Malaysia
11. Largest Asian Cancer Hospital to Evaluate New CT Laser Breast Imaging System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... November 25, 2014 Global biostimulants ... 2019 growing at an estimated CAGR of 12.5%. ... healthy food products with least ecological impacts, farmers ... fertilizers to boost crop yield more effectively & ... that can improve the return on investments. , ...
(Date:11/26/2014)... November 26, 2014 2014 Deep ... an in-depth research report on the Global Palmitic ... introduces Palmitic Acid, basic information, including definition, classification, ... and news analysis, etc. , For international ... Palmitic Acid market in China and other ...
(Date:11/26/2014)... 2014  Roka Bioscience, Inc. (NASDAQ: ROKA ), ... for the detection of foodborne pathogens, today announced that ... 26 th Annual Healthcare Conference on December 2, 2014 ... New York Palace in New York, NY ... the Company, its operations, strategies and prospects may be discussed. ...
(Date:11/24/2014)... , Nov. 24, 2014 VolitionRx Limited ... tests for cancer and other conditions, today announced that data ... the Science for Business BioWin Day 2014, being held November ... data come from VolitionRx,s lung cancer pilot study, the samples ... Centre Hospitalier Universitaire (CHU) de Liege in Belgium ...
Breaking Biology Technology:2019 Biostimulants Market to Grow at a CAGR of 12.5% Says a New Research Report Available at RnRMarketResearch.com 22019 Biostimulants Market to Grow at a CAGR of 12.5% Says a New Research Report Available at RnRMarketResearch.com 32019 Biostimulants Market to Grow at a CAGR of 12.5% Says a New Research Report Available at RnRMarketResearch.com 4Palmitic Acid Industry Global 2014 Analysis & 2020 Forecasts on Market data, Statics, Development Now at ReportsnReports.com 2Palmitic Acid Industry Global 2014 Analysis & 2020 Forecasts on Market data, Statics, Development Now at ReportsnReports.com 3Roka Bioscience to Present at the Piper Jaffray Healthcare Conference 2VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 2VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 3VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 4VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 5VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 6
... US to incorporate partially absorbable mesh for use in ... improve healing and patient comfort , ... & Urology, a division of Ethicon, Inc., a Johnson ... Pelvic Floor Repair System is now available in the ...
... Ltd., a,privately-held drug development company with its headquarters ... new Phase IIa clinical testing of,ProtoCure(TM) emulsion cream, ... vehicle-controlled study is designed to,evaluate the tolerability, pharmacokinetics, ... of 18 subjects with mild to moderate plaque ...
... March 12 Helix BioPharma Corp. (TSX, FSE: "HBP") ... been declared effective by the U.S. Securities and Exchange ... the SEC pursuant to Section 12(g) of the Securities ... shares in the United States allows its shares to ...
Cached Biology Technology:GYNECARE PROLIFT+M(TM) Pelvic Floor Repair System Launched in US for Use in Pelvic Organ Prolapse Surgery 2GYNECARE PROLIFT+M(TM) Pelvic Floor Repair System Launched in US for Use in Pelvic Organ Prolapse Surgery 3BioCis Pharma Starts Phase IIa Trial in Psoriasis 2Helix BioPharma Form 20-F Registration Statement Declared Effective by SEC 2Helix BioPharma Form 20-F Registration Statement Declared Effective by SEC 3
(Date:11/7/2014)...  In conjunction with the Glendale ... Foundation of the Verdugos has announced the " GLENDALE ... $250,000 initiative to keep the Verdugo Regional Crime Lab operational ... months of existence, the Lab has processed more than 400 ... enforcement. "Because our number one priority is the ...
(Date:11/6/2014)... 2014 - Insilico Medicine, Inc, a Baltimore-based bioinformatics ... related diseases announced a research collaboration with the ... Oncology, Inc (OTC: CSBR). , "There are many ... but Champions Oncology,s TumorGraft technology is unique in ... regimen experimentally generating vast amounts of valuable data. ...
(Date:11/4/2014)... the right time might actually help boost a species, ... in understanding animal populations, pest control and managing fish ... journal Trends in Ecology and Evolution , a ... kind of positive population effect an overall species experiences ... the size and developmental stage of the creatures that ...
Breaking Biology News(10 mins):Community Foundation Of The Verdugos Unveils Campaign To Fund Glendale-Burbank DNA Justice Project 2Insilico Medicine, Inc announces research collaboration with Champions Oncology, Inc 2When less is more: Death in moderation boosts population density in nature 2
... Crop growth, drinking water and recreational water sports could ... patterns over the coming years prove true, according to ... of Soils . Scientists from Biotechnology and Biological ... for the first time that the rate at which ...
... the Frances and Joseph Weinberg Unit for ALS ... Thomas Jefferson University was recently awarded a Margaret ... drug therapies that showed promise in Amyotrophic Lateral ... human clinical trials. Dr. Pasinelli and her ...
... lead an international initiative to develop standards for sharing ... Internet. Dr Kerry Taylor and Amit Parashar ... Wide Web Consortium,s (W3C) Semantic Sensor Network incubator group. ... different types of sensing devices, and a new standard ...
Cached Biology News:Changing climate will lead to devastating loss of phosphorus from soil 2Jefferson researcher awarded Landenberger Foundation grant for ALS research 2
Mouse polyclonal antibody raised against a partial recombinant DDEF2. NCBI Entrez Gene ID = 8853...
Mouse monoclonal antibody raised against a partial recombinant QARS. NCBI Entrez Gene ID = QARS...
Mouse monoclonal antibody raised against a partial recombinant QPCT. NCBI Entrez Gene ID = QPCT...
... need to perform time consuming and inaccurate comparison ... any found variants of the sample when compared ... our mutation electropherogram as a sharp peak. ... mode is over 99%, with sensitivity to greater ...
Biology Products: